Publications:

Effect size estimates from umbrella designs: Handling patients with a positive test result for multiple biomarkers using random or pragmatic subtrial allocation.

Plos One

Kesselmeier, Miriam M; Benda, Norbert N; Scherag, André A

Publication Date: 2020

Variant appearance in text: BRCA2: F62E

PubMed Link: 32797088

Variant Present in the following documents:

• Main text

View BVdb publication page

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.

Gynecologic Oncology

Boland, Julia L JL; Zhou, Qin Q; Martin, Madhuri M; Callahan, Margaret K MK; Konner, Jason J; O'Cearbhaill, Roisin E RE; Friedman, Claire F CF; Tew, William W; Makker, Vicky V; Grisham, Rachel N RN; Hensley, Martee L ML; Zecca, Nicholas N; Iasonos, Alexia E AE; Snyder, Alexandra A; Hyman, David M DM; Sabbatini, Paul P; Aghajanian, Carol C; Cadoo, Karen A KA; Zamarin, Dmitriy D

Publication Date: 2019-02

Variant appearance in text: BRCA2: F62E

PubMed Link: 30470581

Variant Present in the following documents:

• Main text

View BVdb publication page